| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NGL FINE-CHEM LTD. (BSE: 524774)
524774 Technical Analysis
5
| As on 19th Apr 2024 524774 SHARE Price closed @ 2544.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1953.43 & Strong Buy for SHORT-TERM with Stoploss of 2077.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
524774SHARE Price
| Open | 2513.55 | Change | Price | % |
| High | 2645.00 | 1 Day | 1.95 | 0.08 |
| Low | 2475.20 | 1 Week | 346.80 | 15.78 |
| Close | 2544.55 | 1 Month | 519.20 | 25.64 |
| Volume | 4344 | 1 Year | 1203.20 | 89.70 |
| 52 Week High 2688.00 | 52 Week Low 1357.00 | ||||
BSE INDIA Most Active Stocks
| 532822 | 12.92 | -2.12% |
| 532775 | 1.75 | -1.13% |
| 532648 | 23.94 | 0.21% |
| 532407 | 135.97 | 2.61% |
| 517001 | 0.09 | 12.50% |
| 512149 | 1.00 | -4.76% |
| 504351 | 2.21 | -2.64% |
| 511700 | 1.89 | 1.61% |
| 530557 | 0.72 | 0.00% |
| 511389 | 7.25 | -2.42% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 524774 Daily Charts |
524774 Intraday Charts |
Whats New @ Bazaartrend |
524774 Free Analysis |
|
|
524774 Important Levels Intraday
| RESISTANCE | 2871.75 |
| RESISTANCE | 2766.82 |
| RESISTANCE | 2701.95 |
| RESISTANCE | 2637.09 |
| SUPPORT | 2452.01 |
| SUPPORT | 2387.15 |
| SUPPORT | 2322.28 |
| SUPPORT | 2217.35 |
524774 Target April 2024
| 4th UP Target | 2720.13 |
| 3rd UP Target | 2518.08 |
| 2nd UP Target | 2393.18 |
| 1st UP Target | 2268.29 |
| 1st DOWN Target | 1911.91 |
| 2nd DOWN Target | 1787.02 |
| 3rd DOWN Target | 1662.12 |
| 4th DOWN Target | 1460.07 |
524774 Weekly Target
| 4th UP Target | 2598.86 |
| 3rd UP Target | 2470.22 |
| 2nd UP Target | 2390.71 |
| 1st UP Target | 2311.19 |
| 1st DOWN Target | 2084.31 |
| 2nd DOWN Target | 2004.79 |
| 3rd DOWN Target | 1925.28 |
| 4th DOWN Target | 1796.64 |
524774 Target2024
| 4th UP Target | 4666.7 |
| 3rd UP Target | 3885.7 |
| 2nd UP Target | 3402.95 |
| 1st UP Target | 2920.19 |
| 1st DOWN Target | 1542.71 |
| 2nd DOWN Target | 1059.95 |
| 3rd DOWN Target | 577.2 |
| 4th DOWN Target | -203.8 |
NGL FINE-CHEM LTD. ( BSE INDIA Symbol : 524774 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
524774 Business Profile
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. The company offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, and S-methoprene for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. It also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India. Address: 301, E Square, Mumbai, India, 400057
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service